You can buy or sell ODT and other stocks, options, ETFs, and crypto commission-free!
Odonate Therapeutics, Inc. Common Stock, also called Odonate Therapeutics, is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. Read More It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Yahoo FinanceApr 25
Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019
SAN DIEGO--(BUSINESS WIRE)-- Odonate Therapeutics, Inc. (ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced financial results for the three months ended March 31, 2019. As of March 31, 2019, Odonate had $112.1 million in cash, compared to $139.1 million as of December 31, 2018. This decrease in cash resulted primarily from net cash used in operating activities of $27.1 million. Odonate’s net l...
Expected Jul 30, Pre-Market